Chinook Therapeutics, Inc. Stock
Equities
KDNY
US16961L1061
Biotechnology & Medical Research
Latest transcript on Chinook Therapeutics, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Noopur Liffick
IRC | Investor Relations Contact | - | 20-09-30 |
Valerie Fauvelle
LAW | General Counsel | - | - |
Sukhi Thethy
AUD | Comptroller/Controller/Auditor | - | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.11% | 0 M€ | 0.00% | - | |
0.09% | 0 M€ | 0.00% | - | |
0.03% | 237 M€ | +1.49% | - |
1st Jan change | Capi. | |
---|---|---|
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.28% | 22.2B | |
-16.53% | 21.23B | |
-9.98% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |